Developer of novel therapeutics designed to treat cancer. The Company's proprietary platform focuses on the tumor microenvironment and data science to identify novel tumor-selective targets and anti-tumor antibodies with unprecedented speed.
Introducing IMPaCT (Integrated Microenvironment Pathway Catalog and Triage)—Resonant Therapeutic's proprietary discovery platform.
No services posted yet
This data is part of our proprietary analytics report:
This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality